Atlas Trials

Sawa Ito, MD

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Sawa Ito, MD

RecordFirmDate
Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies (NCT07565220)Sawa Ito, MD2026-07-27
Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation (NCT06529731)Sawa Ito, MD2024-09-23
IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation (NCT04628338)Sawa Ito, MD2021-03-08

Track Sawa Ito, MD automatically

Every clearance here is in the API, with alerts when new ones post.